A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer
Status:
Unknown status
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
30 patients with advanced colorectal cancer will be enrolled to observe the efficacy and
safety of raltitrexed combined with apatinib as a third-line treatment.